一个25.8M UC San Diego项目使用人工智能和3D生物印记来创建病人特有的肝脏,目的是解决美国器官短缺问题。 A $25.8M UC San Diego project uses AI and 3D bioprinting to create patient-specific livers, aiming to solve the U.S. organ shortage.

在ARPA-H的支持下,一个价值2 580万美元的UC San Diego项目正在利用患者专用细胞和AI优化血管网络推进3D生物指纹肝脏。 A $25.8 million UC San Diego project, backed by ARPA-H, is advancing 3D bioprinted livers using patient-specific cells and AI-optimized vascular networks. 该小组由陈少晋牵头,旨在创建可移植的功能性肝脏,以应对美国器官短缺问题,每年可能挽救12 000多人的生命。 Led by Shaochen Chen, the team aims to create transplantable, functional livers to combat the U.S. organ shortage, potentially saving over 12,000 lives yearly. 这项研究利用FRESH生物印刷和临床级细胞制造,可以消除捐助者依赖和免疫抑制药物。 The research, using FRESH bioprinting and clinical-grade cell manufacturing, could eliminate donor dependence and immunosuppressive drugs. 虽然临床使用已有多年,但这一突破可能扩展到其他器官,并改善全球获得救命治疗的机会。 While still years from clinical use, the breakthrough may extend to other organs and improve global access to life-saving treatments.